Medicare drug price negotiation: Preparing for maximum fair prices and their systemwide impact
Jamie Miller
The passing of the Inflation Reduction Act included a provision allowing the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum fair prices (MFPs) for specific drugs covered under Medicare Part D. The goal is to make medications more affordable for Medicare members and reduce overall costs
